Camsing Healthcare’s Operating Cash Outflow Widened to S$627,000; No Dividend Recommended

Camsing Healthcare Limited (SGX: BAC) recommended no dividend for the six months ended 31 July 2026. Its results, announced on 14 September, show a sharper question for dividend investors: the group used S$627,000 in operating cash, compared with S$344,000 a year earlier. The company said it and/or the group recorded losses during the period. [S1, p. 8] [S1, p. 26] [S1, p. 27]

A better quarter did not rescue the half-year

The latest quarter’s loss attributable to owners narrowed to S$238,000 from S$408,000 a year earlier. For the full six months, though, the loss widened to S$537,000 from S$423,000. These interim results were neither audited nor reviewed. [S1, p. 3] [S1, p. 23]

Six-month revenue fell to S$1.70 million from S$2.08 million. The company attributed much of the decline to the absence of corporate sales, which had contributed S$315,000 in the comparable period. Retail and online sales also slipped. [S1, p. 3] [S1, p. 11] [S1, p. 24]

Other income fell to S$29,000 from S$330,000. Camsing said the earlier period included items such as a lease-termination gain that did not recur. Lower marketing, administrative and finance costs helped the latest quarter, but did not prevent a larger half-year loss. [S1, p. 3] [S1, p. 24] [S1, p. 25]

Loans kept the cash balance steady

The cash-flow statement is the clearest constraint on a payout. Operations used S$627,000 despite a S$124,000 release of cash from inventories. Movements in receivables and payables absorbed cash. [S1, p. 8]

During the same six months, Camsing received S$500,000 in loans from a controlling shareholder and S$300,000 from a third-party lender. Financing activities supplied a net S$632,000 after interest and lease payments. Cash ended July at S$44,000, only slightly above the S$41,000 held at the start of the period. That stable closing balance depended on financing while operations consumed cash. [S1, p. 8]

Group borrowings rose to S$4.116 million at 31 July from S$3.303 million at 31 January. Of the July total, S$2.360 million was classified as current. This includes S$1.105 million owed to a former controlling shareholder who undertook not to require settlement within 12 months from 2 July 2026. That undertaking addresses one repayment demand; the group still needs cash to run its business and meet other obligations. [S1, p. 10] [S1, p. 19]

What the no-dividend decision signals

The group reported net liabilities of S$6.725 million. Management said its losses, deficit, low cash and borrowings create material uncertainty about its ability to continue operating. Its going-concern basis relies in part on a controlling shareholder’s undertaking to provide or procure financial support. [S1, p. 10]

Camsing also issued 50 million shares in May when S$2.5 million of existing convertible bonds converted, lifting issued shares from 90 million to 140 million. The conversion moved an existing reserve into share capital; it did not bring in fresh cash during this period. Any future per-share payout would be measured across the larger share base. [S1, p. 6] [S1, p. 21]

For now, the reported losses and operating cash outflow support a cautious reading of the no-dividend result. The next useful evidence is whether operations use less cash and the group can meet obligations with less new financing, even if another quarterly accounting loss narrows. [S1, p. 8] [S1, p. 10] [S1, p. 27]